| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d75d1a4caed60a9316608ed9c231546c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-23 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
1995-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9591bb3c39dbc10c7e02f4b9f71d496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d280d2553941880542bfd791e4add6b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd6877a92b90a2f0c0f3098150a5aef0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1aa882c1b4c43c0dd2ec294c2e31278 |
| publicationDate |
1996-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0690125-A2 |
| titleOfInvention |
Process for induction culture of cytotoxict lymphocytes having killing activity against tumor cells |
| abstract |
A process for an induction culture of a cytotoxic T lymphocyte having cell killing activities against a tumor cell which comprises the step of coculturing a tumor tissue containing said tumor cell and a lymphocyte of autologous peripheral blood obtained from a subject from which the tumor tissue is derived. The process is convenient since no separation and pure culture of tumor cells is required. The resulting cytotoxic T lymphocyte cells are useful for clinical treatments of tumors, e.g. adoptive immunotherapies. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1479760-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004101773-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008099088-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0129191-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0047226-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008099088-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2911346-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7247310-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9848000-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9848000-A2 |
| priorityDate |
1994-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |